BIIB
NASDAQStockBiogen Inc.
$186.20-4.32 (-2.27%)
52-Week Range
$113.38
$201.18
Key Stats
Market Cap
27.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.14
Volume
454.6K
Avg Volume
897.5K
Performance
1M
+0.79%
3M
+9.41%
6M
+32.91%
YTD
+7.12%
1Y
+35.87%
3Y
-27.39%
5Y
-26.78%
Price Chart
ETF Exposure
BIIB is held by 325 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PBE | Invesco Biotechnology & Genome ETF | 5.07% |
| IBRN | iShares Neuroscience and Healthcare ETF | 4.17% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 4.11% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.59% |
| SYE | SPDR MFS Systematic Core Equity ETF | 3.44% |
| BBH | VanEck Biotech ETF | 3.32% |
| FRTY | Alger Mid Cap 40 ETF | 3.25% |
| LNGR | Global X Aging Population ETF | 3.25% |
| MNTL | Tema Neuroscience And Mental Health ETF | 3.21% |
| MEDX | Horizon Kinetics Medical ETF | 2.90% |
| PJP | Invesco Pharmaceuticals ETF | 2.81% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 2.48% |
| FXH | First Trust Health Care AlphaDEX Fund | 2.45% |
| IBB | iShares Biotechnology ETF | 2.40% |
| FLOW | Global X - U.S. Cash Flow Kings 100 ETF | 2.27% |
| BMED | iShares Health Innovation Active ETF | 2.15% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 2.10% |
| QQQG | Pacer Nasdaq-100 Top 50 Cash Cows Growth Leaders ETF | 2.05% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 2.03% |
| INVN | Alger Russell Innovation ETF | 1.91% |
| CALF | Pacer US Small Cap Cash Cows ETF | 1.90% |
| SAGP | Strategas Global Policy Opportunities ETF | 1.85% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 1.84% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.79% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 1.79% |
| HVAL | ALPS Hillman Active Value ETF | 1.79% |
| BBP | Virtus Biotech ETF | 1.65% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 1.60% |
| BAD | B.A.D. ETF | 1.53% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 1.43% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 1.40% |
| JHMH | John Hancock Multifactor Health Care ETF | 1.39% |
| XBI | State Street SPDR S&P Biotech ETF | 1.30% |
| FCFY | First Trust S&P 500 Diversified Free Cash Flow ETF | 1.02% |
| JDOC | JPMorgan Healthcare Leaders ETF | 1.01% |
| SYV | SPDR MFS Systematic Value Equity ETF | 0.98% |
| FTA | First Trust Large Cap Value AlphaDEX Fund | 0.91% |
| AVMV | Avantis U.S. Mid Cap Value ETF | 0.81% |
| CLRG | IQ Chaikin U.S. Large Cap ETF | 0.79% |
| FLRG | FIDELITY U.S. MULTIFACTOR ETF | 0.76% |
| WDNA | WisdomTree BioRevolution Fund | 0.72% |
| ULVM | VictoryShares US Value Momentum ETF | 0.71% |
| SMOT | VanEck Morningstar SMID Moat ETF | 0.71% |
| SYG | SPDR MFS Systematic Growth Equity ETF | 0.68% |
| STNC | Hennessy Sustainable ETF | 0.65% |
| COWZ | Pacer US Cash Cows 100 ETF | 0.63% |
| FCTR | First Trust Lunt U.S. Factor Rotation ETF | 0.61% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.58% |
| NXTV | Simplify NEXT Intangible Value Index ETF | 0.58% |
| RSPE | Invesco ESG S&P 500 Equal Weight ETF | 0.58% |
Page 1 of 7Next
About BIIB ETF Exposure
Biogen Inc. (BIIB) is held by 325 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 27.3B, BIIB is a widely held institutional stock. The stock currently trades at $186.20. Investors can gain exposure to BIIB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BIIB, sorted by portfolio weight.